ArticleBMC medicine2021

Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study.

Yongchang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.